CCM
ETRM

Coe Capital Management’s EnteroMedics Inc. ETRM Stock Holding History

Coe Capital Management’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-357
Closed -$764K – 290
2013
Q4 		$764K Buy
357
+214
+150% +$345K 0.27% 119
2013
Q3 		$187K Buy
+143
New +$166K 0.13% 99

Other funds holding ETRM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return

Coe Capital Management's ETRM Position: Q1 2014 in Review

Coe Capital Management sold out of EnteroMedics Inc. (ETRM) in Q1 2014, closing a stake of 357 shares — an estimated $764K sold.

Coe Capital Management first reported a position in ETRM in Q3 2013 and held it in 2 quarters. The position peaked at $764K in Q4 2013. 57 funds tracked by Wall St. Rank hold ETRM as of Q1 2014.

  • Coe Capital Management reported no remaining EnteroMedics Inc. position as of Q1 2014 after selling out during the quarter.
  • Coe Capital Management sold 357 EnteroMedics Inc. shares in Q1 2014, an estimated $764K.
  • Coe Capital Management first reported a position in EnteroMedics Inc. in Q3 2013 and held it in 2 quarters.
  • Coe Capital Management's EnteroMedics Inc. position peaked at $764K in Q4 2013.
  • 57 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q1 2014.

Based on Coe Capital Management's 13F filing for Q1 2014, filed 14 May 2014.